Ingredient supplier RFI Ingredients has launched Cranova, a cranberry ingredient platform designed to expand the berry's applications beyond traditional urinary health supplements into areas including gut health, women's and men's health, oral care and healthy ageing.
The portfolio features cranberries grown and processed in the US, combining whole-fruit ingredients with powders standardised to different levels of proanthocyanidins (PACs), alongside cranberry-derived fibre, protein and seed oil.
Cranova's whole-fruit powders are available standardised to 1.5%, 4.0% and 7.2% total PACs.
At a 500 mg serving, these specifications provide 7.5 mg, 20 mg and 36 mg of total PACs, respectively.
The range also includes certified organic options, with whole-fruit selections incorporating different components of the cranberry, including its skin, seeds and pomace.
This provides formulators with alternatives to ingredients focused primarily on PAC content.
According to RFI Ingredients, the platform is intended to give supplement, functional food and beverage manufacturers greater flexibility when developing cranberry-based products for everyday wellness applications.
"Cranberry has a strong identity in urinary health, but there is a much broader ingredient story within the berry," said Jeff Wuagneux, founder and CEO of RFI Ingredients.
With Cranova, we are bringing together US sourcing, whole-food expertise and multiple ingredient options to help brands innovate.
RFI Ingredients expands its ingredient and technology portfolio
Cranova is among several developments for RFI in the last year as the company expands its offering across the dietary supplement, functional food and beverage sectors.
In July, RFI announced a strategic growth partnership with global agrifood investment firm Astanor, which acquired a minority interest in the business.
The investment is intended to support international expansion, particularly in Europe and Asia-Pacific, alongside further ingredient innovation, clinical research and potential acquisitions.
RFI has also been strengthening its advanced delivery technology offering. In May, it partnered with Canadian company Aventus Innovations to support the US commercialisation of NutraJIT, a sustained-release delivery platform designed to protect active ingredients from gastric degradation.